Macrogenics Inc Receivables Turnover Ratio (MGNX), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Macrogenics Inc   (NASDAQ: MGNX)
 

Macrogenics Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Macrogenics Inc 's ability to collect accounts receivable sequentially worsen to 2.83, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Macrogenics Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 129 days, from 61 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 493 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 1536 to 2280.

What is Receivable Turnover Ratio?
What is Macrogenics Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MGNX Receivables Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Receivable Change 1050.44 % -1.12 % 210.35 % 691.2 % 102.42 %
Y / Y Revenue Change 47.62 % 57.48 % 113.03 % -34.21 % 105.99 %
Receivable Turnover Ratio (TTM) 2.83 5.95 5.66 5.28 18.32
MGNX's Total Ranking # 2280 # 1536 # 1213 # 2167 # 1217
Accounts Receivable average collection period days 129 61 65 69 20
Seq. Receivable Change 1282.95 % -22.04 % -80.68 % 452.43 % 18.87 %
Seq. Revenue Change 58.04 % -49.61 % -43.4 % 227.5 % 68.59 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 162
Healthcare Sector # 494
Overall Market # 2280

Receivable Turnover Ratio Statistics
High Average Low
40.26 11.8 2.83
(Dec 31 2015)   (Jun 30 2026)




  News about Macrogenics Inc Receivables Turnover Ratios

MacroGenics Under Scrutiny A Call to Action for Investors Amid Class Action Lawsuit,

In the evolving landscape of biotechnology investments, the recent developments surrounding MacroGenics, Inc. (NASDAQ: MGNX) have caught the attention of both seasoned investors and industry analysts alike. The Rosen Law Firm, a well-regarded entity in the realm of investor rights, has issued a reminder for those who purchased stock or sold puts in MacroGenics between March 7, 2024 and May 9, 2024, regarding a crucial class action lawsuit that poses significant implications for affected shareholders. Background on MacroGenics, Inc. and the Class ActionMacroGenics, a biotechnology company focused on the development of innovative monoclonal antibody therapies for the treatment of cancer, has seen fluctuations in its stock price amidst the ongoing challenges and opportunities of the biopharmaceutical sector. Within the defined Class Period, numerous investors are believed to have incurred losses exceeding $100,000, prompting the Rosen Law Firm to step in and advocate for their rights.


MGNX Company Profile • Back to MGNX Efficiency Comparisons • Compare MGNX Receivables Turnover Ratio to its Competitors

Financial Statements
Macrogenics Inc 's Accounts Receivable $ 144 Millions Visit MGNX's Balance sheet
Macrogenics Inc 's Sales TTM $ 168 Millions Visit MGNX's Income Statement
Sources of MGNX's Revenues Visit MGNX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
MGNX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
MGNX's Growth Rates MGNX's Roa MGNX's Inventory Turnover Ratio MGNX's Dividend Comparisons
MGNX's Profitability Ratios MGNX's Roi MGNX's Asset Turnover Ratio MGNX's Dividend Growth
MGNX's Valuation Ratios MGNX's Roe MGNX's Financial Strength Ratios MGNX's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Collegium Pharmaceutical Inc   3.14 $ 751.744  Millions$ 239.785  Millions
Elite Pharmaceuticals Inc   3.11 $ 140.130  Millions$ 45.059  Millions
Docgo Inc   3.10 $ 294.721  Millions$ 95.023  Millions
Dbv Technologies S a   3.08 $ 5.018  Millions$ 1.631  Millions
Tenon Medical Inc   3.07 $ 5.312  Millions$ 1.731  Millions
Autolus Therapeutics Plc  3.04 $ 117.390  Millions$ 38.576  Millions
Organogenesis Holdings Inc   3.03 $ 457.454  Millions$ 151.020  Millions
Recursion Pharmaceuticals Inc   2.94 $ 54.855  Millions$ 18.634  Millions
Adc Therapeutics Sa  2.86 $ 79.584  Millions$ 27.779  Millions
Macrogenics Inc   2.83 $ 167.674  Millions$ 59.300  Millions
Fennec Pharmaceuticals Inc   2.80 $ 59.221  Millions$ 21.148  Millions
Cormedix Inc   2.80 $ 451.943  Millions$ 161.480  Millions
Upstream Bio Inc   2.79 $ 3.158  Millions$ 1.134  Millions
Harrow Inc   2.69 $ 274.724  Millions$ 102.078  Millions
Surrozen Inc   2.66 $ 11.511  Millions$ 4.329  Millions
Electromed Inc   2.64 $ 72.076  Millions$ 27.317  Millions
Onemednet Corporation  2.61 $ 1.590  Millions$ 0.609  Millions
American Shared Hospital Services  2.58 $ 30.210  Millions$ 11.732  Millions
Aclarion Inc   2.57 $ 0.084  Millions$ 0.033  Millions
Journey Medical Corp  2.50 $ 68.181  Millions$ 27.251  Millions
Cardiff Oncology Inc   2.49 $ 0.508  Millions$ 0.204  Millions
Hyperfine Inc   2.39 $ 15.425  Millions$ 6.458  Millions
Arbutus Biopharma Corp  2.35 $ 181.720  Millions$ 77.420  Millions
Tg Therapeutics Inc   2.34 $ 799.536  Millions$ 341.156  Millions
Abcellera Biologics Inc   2.30 $ 66.174  Millions$ 28.812  Millions
Cumberland Pharmaceuticals Inc   2.27 $ 31.269  Millions$ 13.764  Millions
Co diagnostics Inc   2.14 $ 0.721  Millions$ 0.337  Millions
Profound Medical Corp   2.14 $ 19.086  Millions$ 8.924  Millions
60 Degrees Pharmaceuticals Inc   2.13 $ 1.111  Millions$ 0.522  Millions
Cardio Diagnostics Holdings Inc   2.10 $ 0.014  Millions$ 0.007  Millions

Date modified: 2026-08-18T17:26:26+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.